• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.09% Nasdaq Up 0.98%

    More On AMARQ

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Amarillo Biosciences Inc. (AMARQ)

    -Other OTC
    0.00 0.00(0.00%) N/A
    Add to Portfolio
    Prev Close:N/A
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.90
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.01 - 0.05
    Volume:0
    Avg Vol (3m):N/A
    Market Cap:0.00
    P/E (ttm):0.00
    EPS (ttm):0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in .

    Headlines

    ยป More Headlines for AMARQ

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amarillo Biosciences, Inc. engages in the development of biologics for the treatment of human and animal diseases. It owns or licenses four issued patents related to the low-dose oral delivery of interferon; and owns one issued patent on its dieta... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback